Terms: = Bone cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Prognosis
40 results:
1. Establishment and validation of a novel lysosome-related gene signature for predicting prognosis and immune landscape in hepatocellular carcinoma.
Li H; Li J; Qu X; Dai H; Liu J; Ma M; Wang J; Dong W; Wang W
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17543-17557. PubMed ID: 37903936
[TBL] [Abstract] [Full Text] [Related]
2. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
Li G; Lei J; Xu D; Yu W; Bai J; Wu G
Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
[TBL] [Abstract] [Full Text] [Related]
3. [Relationship between marked hyperferritinemia and hemophagocytic lymphohistiocytosis].
Gao WB; Shi MJ; Zhang HY; Wu CB; Zhu JH
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):921-927. PubMed ID: 34650295
[TBL] [Abstract] [Full Text] [Related]
4. Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor prognosis IGHV- Unmutated Chronic Lymphocytic Leukemia.
Maharaj D; Srinivasan G; Abreu MM; Ko MW; Jewett A; Gouvea J
Cells; 2020 Dec; 10(1):. PubMed ID: 33375215
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy of different regimens in nasal NK/T-cell lymphoma and analysis of serum inflammation and prognosis of patients.
Zhang L; Huang Y; Wang Y
J BUON; 2020; 25(4):1997-2002. PubMed ID: 33099944
[TBL] [Abstract] [Full Text] [Related]
6. Autoimmune hematologic complications of umbilical cord blood transplantation.
Ibrahim U; Keyzner A
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):104-109. PubMed ID: 32882204
[TBL] [Abstract] [Full Text] [Related]
7. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
Guo Z; Tang Y; Fu Y; Wang J
Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
[TBL] [Abstract] [Full Text] [Related]
8. In Vitro Killing of Colorectal Carcinoma Cells by Autologous Activated NK Cells is Boosted by Anti-Epidermal Growth Factor Receptor-induced ADCC Regardless of RAS Mutation Status.
Turin I; Delfanti S; Ferulli F; Brugnatelli S; Tanzi M; Maestri M; Cobianchi L; Lisini D; Luinetti O; Paulli M; Perotti C; Todisco E; Pedrazzoli P; Montagna D
J Immunother; 2018 May; 41(4):190-200. PubMed ID: 29293164
[TBL] [Abstract] [Full Text] [Related]
9. Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2.
Meazza C; Cefalo G; Massimino M; Daolio P; Pastorino U; Scanagatta P; Morosi C; Podda M; Ferrari A; Terenziani M; Spreafico F; Casanova M; Parafioriti A; Collini P; Gandola L; Bastoni S; Biassoni V; Schiavello E; Chiaravalli S; Puma N; Bergamaschi L; Luksch R
Med Oncol; 2017 Nov; 34(12):191. PubMed ID: 29094224
[TBL] [Abstract] [Full Text] [Related]
10. Vγ9Vδ2 T cells and zoledronate mediate antitumor activity in an orthotopic mouse model of human chondrosarcoma.
Sun L; Li Y; Jiang Z; Zhang J; Li H; Li B; Ye Z
Tumour Biol; 2016 Jun; 37(6):7333-44. PubMed ID: 26676633
[TBL] [Abstract] [Full Text] [Related]
11. Adjuvant Ovarian Suppression, High-dose Chemotherapy and Immunotherapy for Premenopausal Patients with High-risk Breast cancer.
Recchia F; Candeloro G; Rosselli M; Bratta M; Pasta V; D'Orazi V; Fumagalli LA; Rea S
Anticancer Res; 2015 Dec; 35(12):6847-53. PubMed ID: 26637906
[TBL] [Abstract] [Full Text] [Related]
12. Expression of CD25 is a specific and relatively sensitive marker for the Philadelphia chromosome (BCR-ABL1) translocation in pediatric B acute lymphoblastic leukemia.
Gaikwad AS; Donohue RE; Elghetany MT; Sheehan AM; Lu XY; Gramatges MM; McClain KL; Mistretta TA; Punia JN; Moore TJ; Goltsova T; Cubbage M; Curry CV
Int J Clin Exp Pathol; 2014; 7(9):6225-30. PubMed ID: 25337274
[TBL] [Abstract] [Full Text] [Related]
13. Elevated soluble il-2 receptor levels correlate with tumor bulk of follicular lymphomas with intestinal involvement.
Iwamuro M; Shinagawa K; Okada H; Takata K; Yoshino T; Yamamoto K
Clin Biochem; 2014 Feb; 47(3):191-5. PubMed ID: 24362271
[TBL] [Abstract] [Full Text] [Related]
14. [Evaluation of selected cytokines in children and adolescents with osteosarcoma at diagnosis - preliminary report].
Markiewicz K; Zeman K; Kozar A; Gołebiowska-Wawrzyniak M
Med Wieku Rozwoj; 2011; 15(1):25-31. PubMed ID: 21786509
[TBL] [Abstract] [Full Text] [Related]
15. Elevated frequencies of CD4⁺ CD25⁺ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia.
Shenghui Z; Yixiang H; Jianbo W; Kang Y; Laixi B; Yan Z; Xi X
Int J Cancer; 2011 Sep; 129(6):1373-81. PubMed ID: 21105040
[TBL] [Abstract] [Full Text] [Related]
16. Lytic activity against primary AML cells is stimulated in vitro by an autologous whole cell vaccine expressing il-2 and CD80.
Hardwick N; Chan L; Ingram W; Mufti G; Farzaneh F
Cancer Immunol Immunother; 2010 Mar; 59(3):379-88. PubMed ID: 19711075
[TBL] [Abstract] [Full Text] [Related]
17. [Clinical values of biomarkers in hematopoietic malignancies].
Kawaguchi T; Nosaka K
Gan To Kagaku Ryoho; 2009 Jan; 36(1):26-31. PubMed ID: 19151562
[TBL] [Abstract] [Full Text] [Related]
18. A study of immunoendocrine strategies with pineal indoles and interleukin-2 to prevent radiotherapy-induced lymphocytopenia in cancer patients.
Lissoni P; Rovelli F; Brivio F; Fumagalli L; Brera G
In Vivo; 2008; 22(3):397-400. PubMed ID: 18610754
[TBL] [Abstract] [Full Text] [Related]
19. Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.
Dieli F; Vermijlen D; Fulfaro F; Caccamo N; Meraviglia S; Cicero G; Roberts A; Buccheri S; D'Asaro M; Gebbia N; Salerno A; Eberl M; Hayday AC
Cancer Res; 2007 Aug; 67(15):7450-7. PubMed ID: 17671215
[TBL] [Abstract] [Full Text] [Related]
20. Treatment of bone metastases and local recurrence from renal cell carcinoma with immunochemotherapy and radiation.
Brinkmann OA; Bruns F; Gosheger G; Micke O; Hertle L
World J Urol; 2005 Jul; 23(3):185-90. PubMed ID: 15838689
[TBL] [Abstract] [Full Text] [Related]
[Next]